Trial Profile
IL-2 Infusion in AML Patients After Autologous Bone Marrow Transplant: A Pediatric Oncology Group Wide Phase I Trial
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Aldesleukin (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 14 Aug 2013 New trial record